Claims for Patent: 10,413,505
✉ Email this page to a colleague
Summary for Patent: 10,413,505
Title: | Pharmaceutical compositions and methods of using the same |
Abstract: | Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described. |
Inventor(s): | Moshal; Jeffrey M. (Allentown, PA), Libman; Michael (Allentown, PA) |
Assignee: | GENUS LIFESCIENCES INC. (Allentown, PA) |
Application Number: | 15/934,562 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,413,505 |
Patent Claims: |
1. A method of providing induction of local anesthesia of mucous membranes in adult patients comprising: soaking four cottonoid pledgets in the contents of one bottle
containing about 4 mL of a pharmaceutical composition comprising about 36 mg/mL to 44 mg/mL of naturally derived cocaine hydrochloride, until each pledget absorbs about 40 mg of naturally derived cocaine hydrochloride, contacting two pledgets in each
nasal cavity against a septum of a patient for a period ranging from about 10 minutes to about 20 minutes, provided that the method results in a maximum plasma concentration C.sub.max in a range from about 19.7 ng/mL to about 54.3 ng/mL of cocaine in the
patient; and performing a procedure on the patient, the procedure selected from the group consisting of a nasal laryngoscopy, a nasopharyngeal laryngoscopy, and a nasal debridement, provided that the method results in a reduction in pain equivalent to
achieving a visual numeric rating score of 0 upon von Frey filament testing.
2. The method of claim 1, wherein the procedure is a nasal laryngoscopy. 3. The method of claim 1, wherein the procedure is a nasopharyngeal laryngoscopy. 4. The method of claim 1, wherein the procedure is a nasal debridement. 5. The method of claim 1, wherein a length of each pledget is from about 3.0 cm to about 8.0 cm. 6. The method of claim 1, wherein a height of each pledget is about 1.3 cm and a length of each pledget is about 4 cm. 7. The method of claim 1, wherein the C.sub.max is about 37 ng/mL. 8. A method of providing induction of local anesthesia of mucous membranes in adult patients comprising: soaking four cottonoid pledgets in the contents of one bottle containing about 4 mL of a pharmaceutical composition comprising about 36 mg/mL to 44 mg/mL of naturally derived cocaine hydrochloride, until each pledget absorbs about 40 mg of naturally derived cocaine hydrochloride; contacting two pledgets in each nasal cavity against a septum of a patient in a range from about 10 minutes to about 20 minutes, provided that the method results in an AUC.sub.inf in a range from about 30.8 ng*h/mL to about 79.0 ng*h/mL of cocaine in the patient; and performing a procedure on the patient, the procedure selected from the group consisting of a nasal laryngoscopy, a nasopharyngeal laryngoscopy, and a nasal debridement, provided that the method results in a reduction in pain equivalent to achieving a visual numeric rating score of 0 upon von Frey filament testing. 9. The method of claim 8, wherein a length of each pledget is from about 3.0 cm to about 8.0 cm. 10. The method of claim 8, wherein a height of each pledget is about 1.3 cm and a length of each pledget is about 4 cm. 11. The method of claim 8, wherein the AUC.sub.inf is about 54.9 ng*h/mL. 12. The method of claim 8, wherein the procedure is a nasal laryngoscopy. 13. The method of claim 8, wherein the procedure is a nasopharyngeal laryngoscopy. 14. The method of claim 8, wherein the procedure is a nasal debridement. 15. The method of claim 8, wherein the achieved AUC.sub.inf ranges from about 30.8 ng*h/mL to about 54.9 ng*h/mL of cocaine in the patient. 16. The method of claim 8, wherein the achieved AUC.sub.inf ranges from about 54.9 ng*h/mL to about 79.0 ng*h/mL of cocaine in the patient. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.